As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
At Medicilon, the importance of analytical support in pharmaceutical development and manufacturing is well understood. We provide our clients with analytical method development and all other services required to support their regulatory needs.
• Analytical Method Development, Qualification and Validation For
• Assay
• Related Compounds
• Water Content
• Chiral Analysis
• Residual Solvents
• Trace Metals Analysis
• IPC and Release Testing
• Impurity Isolation and Structure Elucidation
• Reference Standard Qualification
• Stability Studies
• PGI Method Development, Validation and Testing
• Specification and Other Regulatory Filing Documentation Preparation
• Chromatography: UPLC, HPLC, LC-MS, GC, GC-HS
• Solid State Characterization: DSC, TGA, XRPD, PSD, Polarized Light Microscopy
• Elemental Analysis: ICP-OES
• Identification: NMR, FT-IR
• General Testing: KF, UV-Vis, Polarimeter
Analytic method development, validation and transfer are key elements of any pharmaceutical development program. This technical brief will focus on development and validation activities applied to drug products. Often considered routine, too little attention is paid to their potential to contribute to overall developmental time and cost efficiency.
Methods are developed and validated to analyze in-process, finished products, stability samples, and swabs to verify the cleanliness of manufacturing equipment.
Typically, methods for in-process, uniformity of dosage units, and dissolution sample analysis are developed and validated using UV, HPLC, UPLC, or GC procedures.
Methods used to perform the chemical assay, identification, related substances/impurities, or chiral purity testing on API and finished drug product are typically developed and validated using HPLC, UPLC, or GC.
Methods developed for stability sample analysis are validated to ensure they are stability-indicating.
All validations follow FDA-ICH guidelines, client-approved protocols, and standard operating procedures.
By working with Medicilon, you gain an experienced partner with a good working knowledge of method validation requirements suitable for different phases of development. To ensure methods meet regulatory requirements, we follow relevant ICH guidelines such as ICH Q2(R1) or compendia guidance in combination with client-specific protocols.
• UV/VIS Spectroscopy
• Fluorescence Spectroscopy
• ELISA
• SDS-PAGE
• Iso-electric Focusing
• Capillary Gel Electrophoresis
• UPLC
• HPLC
• Atomic Adsorption
• FTIR
• Peptide Mapping
• Carbohydrate Analysis
• Cell-Based Assays
HPLC Methods: HPLC methods with various high-resolution analytical columns represent the most effective and efficient means of monitoring various degradation of protein therapeutics.
• Size-Exclusion Chromatography
• Ion-Exchange Chromatography
• Reversed Phase Chromatography
• Hydrophobic Interaction Chromatography
• Various Detectors: UV, Fluorescence, Reflective Index, Evaporative Light Scattering, Mass Spectrometry
The wide variety of equipment, columns, eluent, and operational parameters involved the high-performance liquid chromatography (HPLC) method, which makes the development seem complex. Following steps:
Step 1 – Selection of the HPLC Method and Initial System
Step 2 – Selection of Initial Conditions
step 3 – Selectivity Optimization
step 4 – System Optimization
step 5 – Method Validation
Structural Analyses: Measure the secondary, tertiary, and quaternary structure of biologically active proteins
• Circular Dichroism
• Fourier Transformed Infrared Spectroscopy
• Fluorescence Spectroscopy
• Differential Scanning Calorimetry
Electrophoresis: Separation of impurities based on both charge and mass makes electrophoresis an excellent orthogonal method
• Capillary Electrophoresis (CE)
• Sodium Dodecyl Sulfate Electrophoresis (SDS-PAGE)
• Protein Analyzer
Email: marketing@medicilon.com
Tel: +86 021 58591500
Tips: Above is part of analytical method development, analytical method development and validation for pharmaceutical. You can also CONTACT US with any question or inquiry you may have. We will be happy to discuss your needs in detail and design an appropriate action plan.